No definition available.
Transitory disorders of carbohydrate metabolism specific to fetus and newborn
P16_TRANSITO_DISORD_CARBOH_METABOLISM_SPECIFIC_FETUS_NEWBO
Endpoint definition
↥Report an error or suggest an improvement for this endpoint codes
Endpoint definition steps |
FinnGen |
|---|---|
Phenotype data |
557745 |
1. Apply sex-specific ruleNone |
557745 |
2. Check conditionsNone |
557745 |
3. Check pre-conditions, main-only, mode, registry filtersRegistry filters: 2 out of 7 registries used, show all original rules. |
526 |
4. Check minimum number of eventsNone |
526 |
5. Include endpointsNone |
526 |
6. Filter based on genotype QC (FinnGen only) |
470 |
Control definitions (FinnGen only)
- Control exclude
- P16_TRANSITO_ENDOCR_METABOLIC_DISORD_SPECIFIC_FETUS_NEWBO
Extra metadata
- Level in the ICD hierarchy
- 3
- First used in FinnGen datafreeze
- DF4
- Parent code in ICD-10
- P7[0-4]
- Name in latin
- Perturbationes transitoriae metabolismi carbohydratorum fetus et neonati specificae
Similar endpoints
↥List of similar endpoints to
Transitory disorders of carbohydrate metabolism specific to fetus and newborn
based on the number of shared cases.
Similar with more cases:
- Transitory endocrine and metabolic disorders specific to fetus and newborn
- Certain conditions originating in the perinatal period
- Any event in hilmo or specialist outpatient
Similar with less cases:
None
Case counts by codes
↥
Summary Statistics
↥-FinRegistry-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | |||
| Whole population | 43469 | 18662 | 24806 |
| Only index persons | 19536 | 8338 | 11198 |
| Unadjusted period prevalence (%) | |||
| Whole population | 0.62 | 0.53 | 0.69 |
| Only index persons | 0.38 | 0.31 | 0.43 |
| Median age at first event (years) | |||
| Whole population | 0.00 | 0.00 | 0.00 |
| Only index persons | 0.00 | 0.00 | 0.00 |
-FinnGen-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | 470 | 257 | 213 |
| Unadjusted period prevalence (%) | 0.09 | 0.09 | 0.10 |
| Median age at first event (years) | 0.00 | 0.00 | 0.00 |
-FinRegistry-
Age distribution of first events
-FinnGen-
Age distribution of first events
-FinRegistry-
Year distribution of first events
-FinnGen-
Year distribution of first events
-FinRegistry-
Cumulative Incidence Function
-FinnGen-
Cumulative Incidence Function
No data
CodeWAS
↥CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.
This is a new tool, please reach out using the contact form for feedback and improvement ideas.
First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.
Matched cohort
- Matched cases
- 497
- Matched controls
- 4868
Code
Vocabulary
Description
Odds Ratio
-log10(p)
N matched cases
N matched controls
P70.4
ICD-10 Finland
Other neonatal hypoglycaemia
+∞
307.7
317
*
P70.0
ICD-10 Finland
Syndrome of infant of mother with gestational diabetes
+∞
153.3
140
*
P70.1
ICD-10 Finland
Syndrome of infant of a diabetic mother
+∞
94.2
88
*
P07.3
ICD-10 Finland
Other preterm infants
9.1
90.9
132
187
Z87.6
ICD-10 Finland
Personal history of certain conditions arising in the perinatal period
5.9
48.7
100
198
P00.0
ICD-10 Finland
Fetus and newborn affected by maternal hypertensive disorders
11.8
34.9
37
33
P22.1
ICD-10 Finland
Transient tachypnoea of newborn
7.2
34.2
54
81
P08.1
ICD-10 Finland
Other heavy for gestational age infants
161.5
29.8
31
*
P59.0
ICD-10 Finland
Neonatal jaundice associated with preterm delivery
5.8
20.6
39
70
WX722
NOMESCO Finland
PEEP
4.9
19.4
45
97
P07.12
ICD-10 Finland
Other low birth weight 2000-2499 g
5.4
15.8
32
61
P59.9
ICD-10 Finland
Neonatal jaundice, unspecified
3.9
12.9
40
108
P05.1
ICD-10 Finland
Small for gestational age
5.6
12.4
24
44
P08.0
ICD-10 Finland
Exceptionally large baby
37.8
12.1
15
*
P21.1
ICD-10 Finland
Mild and moderate birth asphyxia
7.8
10.3
23
30
P70.3
ICD-10 Finland
Iatrogenic neonatal hypoglycaemia
+∞
9.3
9
*
P05.0
ICD-10 Finland
Light for gestational age
9.1
9.0
18
20
P85
ICPC
Mental retardation
3.8
8.7
27
73
R62.0
ICD-10 Finland
Delayed milestone
2.4
8.6
60
259
AA5HE
NOMESCO Finland
Brain ultrasound examination in a child
2.5
7.9
52
219
P61.1
ICD-10 Finland
Polycythaemia neonatorum
79.6
7.4
8
*
P39.9
ICD-10 Finland
Infection specific to the perinatal period, unspecified
4.4
6.8
17
39
Z38.3
ICD-10 Finland
Twin, born in hospital
11.0
6.2
11
10
RL130, ,
NOMESCO Finland
3.8
6.2
19
51
LabWAS
↥OMOP Concept
People with measurements
Mean N measurements
Mean measured value
(ID) Name
N Cases
N Controls
OR
-log10(p)
cases
controls
cases
controls
unit
-log10(p)
N cases
N controls
54
305
1.82
3.87
3.0
4.9
7.18
51.24
mg/mmol
0.50
43
253
26
113
2.32
3.74
2.4
2.4
0.10
0.11
nmol/l
0.10
19
93
63
410
1.58
2.72
2.4
2.4
4.18
5.81
u/l
1.47
39
247
58
379
1.56
2.47
2.3
2.4
5.69
6.34
iu/l
0.23
43
240
7
18
3.85
2.21
1.0
1.2
—
—
—
0
0
6
14
4.24
2.11
1.0
1.3
—
—
—
0
0
392
3574
1.35
2.01
18.2
16.7
4.00
3.94
mmol/l
2.38
382
3461
245
2107
1.27
1.94
11.0
10.7
5.88
5.89
mmol/l
0.02
225
2006
15
70
2.13
1.90
1.0
1.0
1.35
1.41
g/l
0.23
15
70
7
22
3.15
1.84
2.9
3.3
21.14
32.82
u/l
—
7
22
204
1724
1.27
1.84
4.2
4.2
68.61
67.51
nmol/l
0.24
195
1645
391
3579
1.33
1.83
18.5
16.7
139.34
139.41
mmol/l
0.25
384
3485
128
1025
1.30
1.75
4.2
4.9
9.65
8.46
mmol/l
1.16
122
972
248
2157
1.25
1.71
7.0
6.7
138.78
131.16
u/l
0.52
235
2039
27
163
1.66
1.63
3.0
1.8
33.52
32.15
%
0.24
21
127
14
69
2.02
1.58
7.6
9.6
5.24
4.80
kpa
1.18
14
69
223
1930
1.24
1.57
20.6
18.1
1.23
1.23
mmol/l
0.11
212
1859
405
4153
0.76
1.56
4.1
3.9
—
—
—
0
0
233
2037
1.23
1.47
17.1
16.0
1.23
1.23
mmol/l
0.68
219
1909
241
2118
1.22
1.43
7.4
7.4
114.43
114.49
ml/min/173m2
0.01
174
1492
11
53
2.06
1.32
3.5
5.4
150.00
151.13
umol/l
—
6
31
104
842
1.27
1.30
4.6
3.9
0.00
0.00
estimate
-0.00
39
301
26
167
1.55
1.27
2.0
1.3
—
—
—
0
0
8
35
2.26
1.25
2.3
2.4
103.88
96.17
g/l
—
8
35
394
3667
1.25
1.24
11.0
10.8
26.53
24.49
u/l
1.09
386
3559
107
878
1.25
1.20
3.8
4.4
0.74
0.81
e6/l
0.14
59
471
74
892
0.78
1.18
2.2
2.5
—
—
—
0
0
139
1180
1.21
1.13
3.9
3.3
0.00
0.00
estimate
0.50
36
248
20
125
1.59
1.11
1.8
1.3
345.10
374.54
ug/g
—
10
74
152
1305
1.20
1.10
5.1
5.0
0.21
0.23
e6/l
0.04
114
933
54
411
1.32
1.09
8.2
10.7
52.47
49.94
ng/l
0.21
54
405
366
3397
1.21
1.09
4.4
4.1
2.14
2.02
mu/l
1.14
346
3229
103
851
1.23
1.09
4.0
3.2
0.00
0.00
estimate
-0.00
32
252
12
195
0.59
0.99
1.5
1.6
0.22
0.20
mg/l
—
5
79
161
1402
1.18
0.98
5.6
5.3
368.87
20.95
e6/l
0.50
123
1033
15
90
1.65
0.98
1.8
2.0
—
—
—
0
0
0
28
0.00
0.98
0.0
1.2
—
242.69
—
0
28
10
53
1.87
0.96
1.0
1.0
—
—
—
0
0
65
518
1.26
0.95
19.0
24.8
1.06
1.06
mg/l
0.02
65
513
(40770918) von Willebrand factor (vWf).activity actual/normal in Platelet poor plasma by Immunoassay
11
61
1.78
0.93
1.5
1.8
128.64
125.82
%
0.05
11
61
334
3095
1.17
0.92
4.1
3.6
14.58
14.44
pmol/l
0.53
306
2760
200
1783
1.17
0.91
4.4
4.0
0.00
0.00
estimate
-0.00
42
318
16
100
1.59
0.91
1.6
1.6
—
—
—
0
0
69
811
0.81
0.90
1.9
2.3
—
—
—
0
0
201
1794
1.16
0.90
4.5
4.0
0.00
3.95
estimate
0.50
39
311
8
42
1.88
0.88
2.3
5.2
5.27
4.91
kpa
—
8
42
257
2345
1.15
0.84
2.9
2.4
5.32
5.30
mmol/l
0.14
236
2146
14
209
0.65
0.83
1.9
1.4
1.18
1.14
g/l
0.29
14
202
103
877
1.19
0.81
3.8
4.5
1.97
2.61
e6/l
0.35
56
470
14
207
0.65
0.80
1.9
1.4
0.21
0.20
g/l
0.39
14
201
0
24
0.00
0.79
0.0
1.1
—
—
—
0
0
0
24
0.00
0.79
0.0
1.2
—
—
—
0
0
126
1096
1.17
0.78
16.7
12.4
5.12
4.99
kpa
1.54
120
1067
11
65
1.67
0.77
1.1
1.4
—
—
—
0
0
200
1802
1.15
0.77
4.4
4.0
0.00
0.00
estimate
-0.00
41
312
20
138
1.44
0.76
4.1
4.7
103.63
87.47
ml/min/173m2
—
8
36
470
4519
1.34
0.75
21.1
20.0
274.63
273.97
e9/l
0.07
451
4308
470
4519
1.34
0.75
20.9
19.9
85.94
85.78
fl
0.28
464
4454
10
58
1.70
0.75
3.0
5.7
22.55
26.92
ug/l
—
10
58
9
54
1.64
0.73
8.9
9.1
—
—
—
0
0
470
4521
1.34
0.73
23.1
21.7
39.31
40.22
%
0.59
464
4457
470
4521
1.34
0.73
21.0
19.9
4.64
4.61
e12/l
0.55
448
4298
13
82
1.57
0.73
4.8
5.4
—
—
—
0
0
22
156
1.40
0.73
1.5
1.7
—
—
—
0
0
9
55
1.61
0.72
1.4
2.9
0.88
3.51
nmol/l
—
9
49
205
1860
1.14
0.70
5.2
5.5
28.31
25.46
u/l
0.50
189
1788
48
385
1.24
0.70
9.2
9.5
525.14
1539.27
ng/l
3.20
42
332
470
4524
1.32
0.69
21.9
20.4
133.22
132.58
g/l
0.45
464
4462
160
1430
1.14
0.68
6.3
5.4
—
—
—
0
0
153
1367
1.14
0.65
10.8
10.9
47.31
27.18
umol/l
2.68
136
1266
15
208
0.70
0.65
1.5
1.3
—
—
—
0
0
8
125
0.62
0.65
1.5
1.5
—
—
—
0
0
29
358
0.78
0.61
3.3
2.2
141.29
159.89
u/ml
0.18
21
159
22
162
1.35
0.60
2.9
3.9
272.12
185.55
e6/l
0.46
17
106
0
19
0.00
0.60
0.0
1.1
—
—
—
0
0
412
3927
1.16
0.60
18.8
19.2
13.21
13.14
%
0.51
403
3871
123
1090
1.14
0.60
16.7
12.2
0.76
0.79
mmol/l
0.05
92
794
0
22
0.00
0.59
0.0
1.1
—
—
—
0
0
16
112
1.41
0.58
6.5
5.8
1.90
2.42
ug/l
0.55
16
112
235
2169
1.12
0.58
3.5
3.0
2.51
2.56
mmol/l
0.48
223
2059
10
63
1.57
0.58
6.2
5.5
0.50
0.79
index
—
10
63
214
1967
1.12
0.57
3.6
2.9
1.11
1.07
mmol/l
0.28
206
1871
245
2269
1.11
0.56
5.3
4.3
15.17
231.07
e6/l
—
6
28
19
139
1.35
0.55
1.4
1.2
201.67
219.84
iu/ml
—
6
38
9
61
1.45
0.53
15.9
11.1
5.19
5.82
pmol/l
—
9
61
9
62
1.43
0.52
6.0
7.7
—
—
—
0
0
112
1204
0.89
0.52
2.8
2.6
—
—
—
0
0
136
1224
1.12
0.52
3.1
3.4
2.65
2.50
mg/l
0.41
124
1106
21
264
0.77
0.52
3.7
2.6
80.40
94.95
au/ml
—
10
113
238
2211
1.10
0.50
3.7
3.2
4.16
4.25
mmol/l
1.14
226
2118
29
346
0.81
0.48
3.0
2.3
43.13
28.30
u/l
0.34
23
273
34
277
1.22
0.46
1.0
1.0
7.53
7.17
kpa
0.45
29
233
34
277
1.22
0.46
1.0
1.0
-2.13
-1.94
mmol/l
—
7
65
5
82
0.59
0.46
1.4
4.4
—
—
—
0
0
5
82
0.59
0.46
1.4
4.4
—
—
—
0
0
19
144
1.30
0.45
2.0
1.4
1.82
3.51
iu/ml
—
5
18
31
364
0.82
0.45
3.0
2.1
—
62.01
—
0
7
22
171
1.27
0.44
1.9
1.7
1008.78
1095.39
nmol/l
0.15
14
132
10
68
1.45
0.43
6.3
5.4
20.70
20.24
index
—
10
63
14
102
1.35
0.43
6.1
2.1
1.37
2.21
mmol/l
—
9
81
8
55
1.43
0.42
1.5
1.7
134.63
128.04
%
—
8
55
8
55
1.43
0.42
1.5
3.0
0.46
1.93
ug/l
—
8
50
5
31
1.59
0.42
1.0
1.2
—
—
—
0
0
220
2050
1.09
0.42
4.4
3.4
35.56
35.19
mmol/mol
0.20
214
1938
8
56
1.41
0.42
1.5
1.7
—
—
—
0
0
0
15
0.00
0.41
0.0
1.0
—
1.54
—
0
7
0
16
0.00
0.41
0.0
1.3
—
—
—
0
0
0
16
0.00
0.41
0.0
2.6
—
—
—
0
0
0
16
0.00
0.41
0.0
2.6
—
—
—
0
0
0
16
0.00
0.41
0.0
2.6
—
—
—
0
0
0
16
0.00
0.41
0.0
2.6
—
—
—
0
0
5
33
1.49
0.40
1.0
1.1
—
104.71
ng/l
—
0
7
0
17
0.00
0.40
0.0
2.4
—
—
—
0
0
21
165
1.26
0.40
3.2
2.5
—
—
—
0
0
16
121
1.30
0.40
1.8
1.8
—
—
—
0
0
13
95
1.35
0.39
1.2
1.3
—
—
—
0
0
12
156
0.75
0.39
1.3
1.4
—
—
—
0
0
117
1063
1.10
0.38
11.1
12.9
1.31
0.82
mmol/l
1.32
90
854
5
36
1.36
0.37
1.4
1.6
—
—
—
0
0
20
240
0.81
0.36
2.0
2.0
—
—
—
0
0
31
258
1.19
0.36
30.0
20.9
15.61
15.59
kpa
0.01
31
250
31
258
1.19
0.36
30.0
20.9
5.19
5.35
kpa
0.53
31
250
6
41
1.44
0.35
2.5
2.0
1.16
5.17
mg/l
—
6
32
6
41
1.44
0.35
2.5
2.0
1.24
1.27
mg/l
—
6
30
6
41
1.44
0.35
2.5
2.0
0.41
0.87
mg/l
—
6
32
6
41
1.44
0.35
2.5
2.0
0.56
1.03
mg/l
—
6
35
6
41
1.44
0.35
2.5
2.0
0.34
2.26
mg/l
—
6
33
6
41
1.44
0.35
2.5
2.0
2.07
2.01
mg/l
—
6
35
6
41
1.44
0.35
2.5
2.0
0.77
3.31
mg/l
—
6
35
6
41
1.44
0.35
2.5
2.0
2.13
3.35
mg/l
—
6
28
39
332
1.16
0.35
2.7
2.1
5.72
7.90
nmol/l
0.98
31
296
20
159
1.24
0.35
2.9
3.9
608.20
561.55
e6/l
0.13
15
104
21
168
1.23
0.35
2.0
2.2
—
—
—
0
0
86
916
0.90
0.35
1.7
2.1
1.45
1.17
mmol/l
0.48
76
857
6
42
1.40
0.35
2.5
2.0
0.40
1.44
mg/l
—
6
34
119
1246
0.92
0.34
2.9
2.7
—
—
—
0
0
29
332
0.85
0.34
1.1
1.2
3.17
7.58
u/ml
2.03
18
223
22
178
1.22
0.34
2.3
2.0
—
—
—
0
0
12
152
0.77
0.34
6.2
10.3
24.07
23.93
mmol/l
0.06
12
145
20
161
1.23
0.32
3.0
4.2
—
—
—
0
0
229
2157
1.07
0.32
3.6
3.0
1.33
1.40
mmol/l
2.94
217
2050
28
234
1.18
0.32
2.4
2.5
—
—
—
0
0
59
637
0.89
0.31
1.3
1.3
—
46.05
—
0
8
25
207
1.19
0.31
23.0
10.3
23.23
23.06
mmol/l
0.17
25
200
10
73
1.35
0.31
1.3
2.2
—
—
—
0
0
96
874
1.09
0.31
3.6
4.5
—
—
—
0
0
15
182
0.80
0.31
3.1
4.8
3.33
3.28
mmol/l
0.13
15
177
242
2288
1.07
0.30
4.2
4.0
51.17
47.88
ug/l
0.18
228
2198
254
2569
0.94
0.29
5.1
4.8
6.72
6.84
mm/h
0.09
238
2403
38
329
1.14
0.29
1.2
1.5
—
—
—
0
0
33
368
0.87
0.29
1.2
1.3
—
—
—
0
0
11
83
1.30
0.28
9.1
12.6
10.04
9.59
mg/l
0.10
11
78
232
2196
1.07
0.27
2.2
2.1
—
—
—
0
0
32
275
1.15
0.27
1.0
1.0
3.16
3.28
kpa
0.17
27
232
56
500
1.11
0.27
2.9
2.3
10.44
35.87
ng/l
0.78
27
169
28
314
0.87
0.27
1.2
1.2
11.77
12.55
u/ml
0.05
19
202
13
157
0.81
0.26
1.3
1.4
—
—
—
0
0
11
85
1.27
0.25
1.3
2.3
—
—
—
0
0
53
475
1.10
0.24
3.4
2.4
497.01
9173.24
u/l
3.43
16
129
21
176
1.18
0.24
40.5
25.0
16.02
15.58
%
0.35
21
171
20
167
1.18
0.24
16.6
16.4
86.20
1016.00
u/ml
—
5
27
15
122
1.21
0.23
2.3
1.6
0.12
0.23
nmol/l
—
10
92
11
86
1.26
0.23
1.2
1.1
—
—
—
0
0
5
39
1.26
0.22
1.4
1.7
7.64
7.48
mmol/l
—
5
39
23
196
1.16
0.22
39.9
26.2
95.41
95.74
%
0.05
23
196
7
93
0.73
0.22
1.0
1.7
—
—
—
0
0
27
298
0.88
0.22
1.3
1.4
—
—
—
0
0
0
10
0.00
0.21
0.0
1.2
—
12.07
—
0
10
0
11
0.00
0.21
0.0
1.5
—
—
—
0
0
0
11
0.00
0.21
0.0
2.4
—
—
—
0
0
0
11
0.00
0.21
0.0
3.1
—
—
—
0
0
0
11
0.00
0.21
0.0
1.0
—
—
—
0
0
0
11
0.00
0.21
0.0
1.5
—
—
—
0
0
8
99
0.79
0.21
1.5
1.3
10.65
14.13
u/ml
—
8
92
54
489
1.09
0.21
23.8
20.3
1.56
1.33
mmol/l
0.83
54
477
0
12
0.00
0.21
0.0
1.5
—
57.75
—
0
12
28
307
0.89
0.21
2.3
1.7
—
—
—
0
0
0
13
0.00
0.20
0.0
5.5
—
3.74
—
0
13
9
109
0.81
0.20
1.8
1.7
—
—
—
0
0
23
255
0.88
0.20
1.6
1.7
—
—
—
0
0
44
468
0.91
0.19
6.1
4.2
2356.38
1068.68
ng/l
0.55
29
254
23
199
1.14
0.19
2.4
2.1
—
—
—
0
0
6
52
1.13
0.18
1.5
1.6
356.17
525.20
pmol/l
—
6
45
10
80
1.23
0.17
1.3
1.3
—
—
—
0
0
44
465
0.92
0.17
1.2
1.2
3.15
3.36
u/ml
0.06
32
340
75
695
1.07
0.17
4.3
3.7
13.19
13.63
umol/l
0.22
70
673
5
65
0.75
0.17
1.0
1.1
4.63
0.70
u/ml
—
5
65
5
66
0.74
0.17
1.0
1.2
—
—
—
0
0
19
164
1.14
0.16
1.3
3.1
—
—
—
0
0
8
70
1.12
0.16
1.0
1.1
—
—
—
0
0
196
1871
1.04
0.16
1.9
1.8
1.45
1.46
g/l
0.02
106
991
28
301
0.91
0.16
1.1
1.2
0.02
1.08
u/ml
1.47
15
165
66
613
1.06
0.15
1.5
1.5
270.19
462.82
u/ml
0.55
58
576
7
88
0.78
0.14
1.1
1.4
86.57
76.85
%
—
7
88
38
400
0.92
0.14
1.3
1.2
—
—
—
0
0
415
4029
1.05
0.14
14.6
13.3
21.91
23.10
mg/l
0.31
317
2883
8
97
0.80
0.13
1.1
1.0
1.31
1.49
g/l
—
8
97
70
654
1.06
0.13
5.4
6.4
1.56
1.97
mg/l
0.38
51
480
22
195
1.11
0.13
41.5
26.2
0.69
0.68
%
0.01
22
195
15
165
0.89
0.12
9.0
22.4
69.43
69.58
%
0.01
15
165
23
206
1.10
0.12
1.3
1.3
219.38
208.31
miu/ml
0.06
13
90
64
654
0.95
0.11
1.1
1.1
—
—
—
0
0
(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay
14
122
1.13
0.10
26.1
29.9
0.41
0.32
iu/ml
—
8
82
133
1334
0.97
0.10
3.8
4.3
—
—
estimate
—
0
0
19
203
0.91
0.10
1.4
1.7
15.79
13.98
u/ml
0.05
11
143
11
122
0.88
0.09
1.0
1.1
—
—
—
0
0
5
45
1.09
0.09
1.2
1.3
108.00
113.49
pmol/l
—
5
45
24
218
1.08
0.09
1.4
1.2
3.04
2.99
mmol/l
0.10
12
119
5
47
1.04
0.09
2.4
5.8
—
—
—
0
0
25
228
1.08
0.09
2.2
2.4
—
—
—
0
0
22
232
0.93
0.09
8.7
18.1
0.62
0.59
%
0.16
22
232
29
267
1.07
0.08
1.4
1.2
3.67
3.17
ratio
0.89
15
158
51
479
1.05
0.08
2.2
2.2
—
—
—
0
0
6
56
1.05
0.08
1.0
1.1
—
—
—
0
0
5
61
0.80
0.08
1.0
1.2
—
—
—
0
0
5
62
0.79
0.08
1.0
1.1
—
—
—
0
0
5
62
0.79
0.08
1.0
1.2
—
—
—
0
0
5
63
0.78
0.08
1.0
1.1
—
—
—
0
0
5
63
0.78
0.08
1.0
1.2
—
—
—
0
0
17
181
0.92
0.08
3.1
5.0
11.90
7.57
e6/l
—
10
124
17
181
0.92
0.08
3.2
5.0
137.17
1023.10
e6/l
0.68
12
128
47
480
0.95
0.08
2.2
2.3
—
—
—
0
0
46
432
1.05
0.08
15.2
18.5
106.24
105.75
mmol/l
0.30
46
432
6
70
0.84
0.07
1.0
1.3
—
—
—
0
0
8
73
1.07
0.07
1.1
1.5
—
—
—
0
0
25
230
1.07
0.07
1.7
1.9
—
—
—
0
0
12
130
0.90
0.07
5.2
3.1
140.42
134.83
g/l
0.23
12
117
19
199
0.93
0.06
6.2
4.1
0.02
0.12
e6/l
3.26
19
190
16
169
0.92
0.06
6.8
6.9
26.89
12.85
umol/l
0.44
16
149
126
1256
0.98
0.06
10.5
10.5
38.17
38.09
g/l
0.05
121
1206
55
556
0.97
0.06
9.2
9.3
5.37
5.96
umol/l
0.28
43
463
18
165
1.07
0.05
3.7
2.4
—
—
—
0
0
45
427
1.04
0.05
1.3
1.2
9.29
16.63
iu/ml
—
7
75
12
127
0.92
0.04
1.7
1.8
—
—
—
0
0
61
584
1.03
0.04
2.1
2.3
—
—
—
0
0
50
478
1.03
0.03
1.2
1.3
8.35
5.83
u/ml
0.37
35
364
11
116
0.93
0.03
1.6
1.5
63.57
57.66
ug/l
0.23
11
116
11
116
0.93
0.03
1.0
1.1
—
—
—
0
0
281
2738
1.01
0.03
12.9
13.2
3.33
3.41
e9/l
0.27
237
2232
49
470
1.02
0.02
1.1
1.3
0.35
1.13
u/ml
2.18
30
340
10
91
1.08
0.02
1.4
1.6
606.60
373.50
mu/l
—
5
74
44
423
1.02
0.01
9.5
12.8
96.57
91.35
%
0.91
44
423
15
140
1.05
0.01
1.5
1.8
—
—
—
0
0
201
1960
1.01
0.01
1.9
1.9
1.65
3.85
u/ml
1.55
40
347
23
232
0.97
0.01
1.5
1.8
—
—
—
0
0
92
894
1.01
0.01
1.7
1.6
106.40
98.26
pmol/l
1.28
47
467
15
153
0.96
0.01
8.1
6.8
100.93
97.46
%
0.13
15
153
11
102
1.06
0.00
1.5
2.0
133.73
142.52
ng/l
0.21
11
97
11
102
1.06
0.00
4.1
1.9
292.27
295.18
mosm/kgh2o
0.27
11
71
95
936
0.99
0.00
3.7
3.0
1.02
1.02
kg/l
0.06
60
575
20
195
1.00
0.00
1.9
1.4
—
—
—
0
0
20
195
1.00
0.00
1.9
1.4
—
—
—
0
0
10
93
1.05
0.00
1.2
1.8
—
—
—
0
0
52
506
1.01
0.00
1.2
1.3
3.72
3.02
u/ml
0.11
37
364
11
107
1.01
0.00
1.5
1.4
—
—
—
0
0
42
407
1.01
0.00
1.3
1.3
211.24
114.79
u/ml
0.59
15
113
20
197
0.99
0.00
28.0
20.2
120.00
120.35
g/l
0.02
20
192
77
751
1.01
0.00
2.9
3.5
82.30
56.02
u/l
0.89
69
701
17
163
1.02
0.00
2.0
2.1
—
—
—
0
0
10
102
0.96
0.00
1.2
1.4
14.97
7.74
u/ml
—
10
96
41
400
1.00
0.00
1.3
1.2
1.01
9.62
u/ml
1.50
16
113
0
7
0.00
0.00
0.0
1.1
—
117.43
—
0
7
0
5
0.00
0.00
0.0
24.2
—
—
—
0
0
7
71
0.97
0.00
2.3
4.6
22.24
23.70
mmol/l
—
7
66
0
8
0.00
0.00
0.0
4.1
—
91.88
—
0
8
0
7
0.00
0.00
0.0
2.0
—
—
—
0
0
0
7
0.00
0.00
0.0
1.3
—
—
—
0
0
0
8
0.00
0.00
0.0
17.0
—
11.28
—
0
8
0
5
0.00
0.00
0.0
4.2
—
—
—
0
0
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
0
8
0.00
0.00
0.0
1.3
—
—
—
0
0
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
271
2651
1.00
-0.00
10.7
11.3
2.55
2.45
e9/l
0.47
233
2231
0
6
0.00
-0.00
0.0
1.0
—
9.83
—
0
6
9
97
0.91
-0.00
1.8
1.0
1.13
0.78
g/l
—
9
97
0
9
0.00
-0.00
0.0
3.6
—
—
—
0
0
0
6
0.00
-0.00
0.0
1.2
—
—
—
0
0
7
68
1.01
-0.00
1.0
1.1
—
—
—
0
0
5
52
0.94
-0.00
1.2
2.5
23.60
21.73
u/ml
—
5
41
6
68
0.86
-0.00
1.2
1.7
—
—
—
0
0
8
82
0.95
-0.00
2.9
2.7
—
—
—
0
0
0
9
0.00
-0.00
0.0
1.6
—
1.23
—
0
9
0
6
0.00
-0.00
0.0
1.2
—
—
—
0
0
0
9
0.00
-0.00
0.0
3.6
—
—
—
0
0
5
52
0.94
-0.00
1.0
1.0
—
—
—
0
0
7
75
0.91
-0.00
1.4
1.2
0.24
1.48
u/ml
—
7
75
6
61
0.96
-0.00
1.0
1.0
—
—
—
0
0
Mortality – FinRegistry
↥Association
Association between endpoint P16_TRANSITO_DISORD_CARBOH_METABOLISM_SPECIFIC_FETUS_NEWBO and mortality.
Females
| Parameter | HR [95% CI] | p-value |
|---|---|---|
| P16_TRANSITO_DISORD_CARBOH_METABOLISM_SPECIFIC_FETUS_NEWBO | 1.634 [1.25, 2.13] | < 0.001 |
| Birth year | 0.989 [0.98, 1.0] | 0.012 |
During the follow-up period (1.1.1998 — 31.12.2019), 62 out of 17625 females with P16_TRANSITO_DISORD_CARBOH_METABOLISM_SPECIFIC_FETUS_NEWBO died.
Males
| Parameter | HR [95% CI] | p-value |
|---|---|---|
| P16_TRANSITO_DISORD_CARBOH_METABOLISM_SPECIFIC_FETUS_NEWBO | 1.08 [0.86, 1.35] | 0.502 |
| Birth year | 0.989 [0.98, 1.0] | 0.022 |
During the follow-up period (1.1.1998 — 31.12.2019), 88 out of 23411 males with P16_TRANSITO_DISORD_CARBOH_METABOLISM_SPECIFIC_FETUS_NEWBO died.
Mortality risk
Mortality risk for people of age
years, who have P16_TRANSITO_DISORD_CARBOH_METABOLISM_SPECIFIC_FETUS_NEWBO.| N-year risk | Females | Males |
|---|---|---|
| 1 | 0.155% | 0.296% |
| 5 | 0.759% | 1.406% |
| 10 | 1.871% | 3.717% |
| 15 | 3.651% | 6.688% |
| 20 | 6.531% | 10.989% |
Relationships between endpoints
↥Index endpoint: P16_TRANSITO_DISORD_CARBOH_METABOLISM_SPECIFIC_FETUS_NEWBO – Transitory disorders of carbohydrate metabolism specific to fetus and newborn
GWS hits: -
Endpoint
Case Overlap
Survival Analysis
Genetic Correlations
Genetic Signals
N (Jaccard index)
HR [CI]
rg [CI]
Hits
Coloc Hits
FinRegistry
FinnGen
FinRegistry
FinnGen
FinnGen
Loading data